Microbot Medical Inc. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Microbot Medical Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Microbot Medical Inc. Debt-to-equity for the quarter ending September 30, 2024 was 38 %, a 68% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 38 +15.4 +68% Sep 30, 2024
Q2 2024 33 +7.53 +29.6% Jun 30, 2024
Q1 2024 29 +0.43 +1.51% Mar 31, 2024
Q4 2023 31.1 +6.25 +25.2% Dec 31, 2023
Q3 2023 22.6 +1.86 +8.95% Sep 30, 2023
Q2 2023 25.4 +9.63 +61% Jun 30, 2023
Q1 2023 28.6 +16 +128% Mar 31, 2023
Q4 2022 24.8 +14.4 +138% Dec 31, 2022
Q3 2022 20.8 +12 +138% Sep 30, 2022
Q2 2022 15.8 +8.18 +107% Jun 30, 2022
Q1 2022 12.5 +5.77 +85.2% Mar 31, 2022
Q4 2021 10.5 +4.33 +70.8% Dec 31, 2021
Q3 2021 8.73 -0.12 -1.36% Sep 30, 2021
Q2 2021 7.62 -6.38 -45.6% Jun 30, 2021
Q1 2021 6.78 -15.1 -69% Mar 31, 2021
Q4 2020 6.12 -29.4 -82.8% Dec 31, 2020
Q3 2020 8.85 -66.3 -88.2% Sep 30, 2020
Q2 2020 14 -45.3 -76.4% Jun 30, 2020
Q1 2020 21.9 -22 -50.2% Mar 31, 2020
Q4 2019 35.5 +8.66 +32.3% Dec 31, 2019
Q3 2019 75.2 +68.4 +1013% Sep 30, 2019
Q2 2019 59.3 +53.5 +925% Jun 30, 2019
Q1 2019 43.9 +38.3 +682% Mar 31, 2019
Q4 2018 26.8 +18.3 +215% Dec 31, 2018
Q3 2018 6.75 -6.28 -48.2% Sep 30, 2018
Q2 2018 5.78 -37.9 -86.7% Jun 30, 2018
Q1 2018 5.62 -428 -98.7% Mar 31, 2018
Q4 2017 8.51 +628 Dec 31, 2017
Q3 2017 13 +493 Sep 30, 2017
Q2 2017 43.7 +829 Jun 30, 2017
Q1 2017 433 +1.52K Mar 31, 2017
Q4 2016 -620 +3.32K +84.2% Dec 31, 2016
Q3 2016 -480 +11.4K +96% Sep 30, 2016
Q2 2016 -785 -1.46K -216% Jun 30, 2016
Q1 2016 -1.09K -2.01K -218% Mar 31, 2016
Q4 2015 -3.93K -4.46K -852% Dec 31, 2015
Q3 2015 -11.9K -12.4K -2325% Sep 30, 2015
Q2 2015 676 -599 -47% Jun 30, 2015
Q1 2015 923 +383 +71% Mar 31, 2015
Q4 2014 523 +108 +25.9% Dec 31, 2014
Q3 2014 535 +303 +131% Sep 30, 2014
Q2 2014 1.28K +1.09K +603% Jun 30, 2014
Q1 2014 540 +378 +233% Mar 31, 2014
Q4 2013 416 +199 +92.2% Dec 31, 2013
Q3 2013 232 -3.65 -1.55% Sep 30, 2013
Q2 2013 181 +17.6 +10.8% Jun 30, 2013
Q1 2013 162 +46.3 +40% Mar 31, 2013
Q4 2012 216 Dec 31, 2012
Q3 2012 236 Sep 30, 2012
Q2 2012 164 Jun 30, 2012
Q1 2012 116 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.